$342 Million is the total value of PURA VIDA INVESTMENTS, LLC's 76 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $25,123,000 | – | 100,000 | +100.0% | 7.35% | – |
| PFE | New | PFIZER INCcall | $17,850,000 | – | 500,000 | +100.0% | 5.22% | – |
| XRAY | New | DENTSPLY SIRONA INC | $9,570,000 | – | 160,000 | +100.0% | 2.80% | – |
| BAX | New | BAXTER INTL INCput | $8,471,000 | – | 135,000 | +100.0% | 2.48% | – |
| XLV | New | SELECT SECTOR SPDR TRput | $8,173,000 | – | 100,000 | +100.0% | 2.39% | – |
| CNC | New | CENTENE CORP DEL | $7,742,000 | – | 80,000 | +100.0% | 2.26% | – |
| AGN | New | ALLERGAN PLC | $7,173,000 | – | 35,000 | +100.0% | 2.10% | – |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $6,374,000 | – | 100,000 | +100.0% | 1.86% | – |
| IWM | New | ISHARES TRput | $5,927,000 | – | 40,000 | +100.0% | 1.73% | – |
| DXCM | New | DEXCOM INC | $5,871,000 | – | 120,000 | +100.0% | 1.72% | – |
| INCY | New | INCYTE CORPput | $5,837,000 | – | 50,000 | +100.0% | 1.71% | – |
| INCY | New | INCYTE CORP | $5,837,000 | – | 50,000 | +100.0% | 1.71% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INCcall | $5,405,000 | – | 70,000 | +100.0% | 1.58% | – |
| QDEL | New | QUIDEL CORP | $4,825,000 | – | 110,000 | +100.0% | 1.41% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $4,546,000 | – | 29,900 | +100.0% | 1.33% | – |
| XBI | New | SPDR SER TRput | $4,329,000 | – | 50,000 | +100.0% | 1.27% | – |
| ABT | New | ABBOTT LABS | $4,269,000 | – | 80,000 | +100.0% | 1.25% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INCcall | $4,234,000 | – | 200,000 | +100.0% | 1.24% | – |
| ABT | New | ABBOTT LABScall | $4,002,000 | – | 75,000 | +100.0% | 1.17% | – |
| New | NABRIVA THERAPEUTICS PLC | $3,481,000 | – | 425,000 | +100.0% | 1.02% | – | |
| FXH | New | FIRST TR EXCHANGE TRADED FDput | $3,371,000 | – | 50,000 | +100.0% | 0.99% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $3,351,000 | – | 37,589 | +100.0% | 0.98% | – |
| IBB | New | ISHARES TRput | $3,336,000 | – | 10,000 | +100.0% | 0.98% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INCcall | $3,068,000 | – | 75,000 | +100.0% | 0.90% | – |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $3,016,000 | – | 200,000 | +100.0% | 0.88% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INCcall | $2,994,000 | – | 25,000 | +100.0% | 0.88% | – |
| SIEN | New | SIENTRA INC | $2,892,000 | – | 187,800 | +100.0% | 0.85% | – |
| BRKS | New | BROOKS AUTOMATION INC NEW | $2,884,000 | – | 95,000 | +100.0% | 0.84% | – |
| INSM | New | INSMED INC | $2,734,000 | – | 87,601 | +100.0% | 0.80% | – |
| DXCM | New | DEXCOM INCcall | $2,691,000 | – | 55,000 | +100.0% | 0.79% | – |
| QGEN | New | QIAGEN NVcall | $2,520,000 | – | 80,000 | +100.0% | 0.74% | – |
| ZGNX | New | ZOGENIX INCcall | $2,194,000 | – | 62,600 | +100.0% | 0.64% | – |
| PTCT | New | PTC THERAPEUTICS INCcall | $2,057,000 | – | 102,800 | +100.0% | 0.60% | – |
| MOH | New | MOLINA HEALTHCARE INC | $1,719,000 | – | 25,000 | +100.0% | 0.50% | – |
| AERI | New | AERIE PHARMACEUTICALS INCput | $1,711,000 | – | 35,200 | +100.0% | 0.50% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INCcall | $1,616,000 | – | 100,000 | +100.0% | 0.47% | – |
| New | SPECTRUM PHARMACEUTICALS INCnote 2.750%12/1 | $1,422,000 | – | 10,000 | +100.0% | 0.42% | – | |
| ZGNX | New | ZOGENIX INC | $1,402,000 | – | 40,000 | +100.0% | 0.41% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $1,378,000 | – | 50,000 | +100.0% | 0.40% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,329,000 | – | 70,000 | +100.0% | 0.39% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $1,229,000 | – | 117,131 | +100.0% | 0.36% | – |
| EXEL | New | EXELIXIS INCcall | $1,226,000 | – | 50,600 | +100.0% | 0.36% | – |
| QDEL | New | QUIDEL CORPput | $1,228,000 | – | 28,000 | +100.0% | 0.36% | – |
| New | INTEC PHARMA LTD JERUSALEM | $895,000 | – | 100,000 | +100.0% | 0.26% | – | |
| MEIP | New | MEI PHARMA INCcall | $527,000 | – | 196,500 | +100.0% | 0.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 27 | Q2 2024 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| LIVANOVA PLC | 26 | Q2 2024 | 3.8% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| ESTABLISHMENT LABS HLDGS INC | 24 | Q2 2024 | 6.6% |
| INSPIRE MED SYS INC | 24 | Q1 2024 | 3.7% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| DEXCOM INC | 23 | Q1 2024 | 1.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Apyx Medical Corp | February 14, 2024 | 80,000 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2024 | 1,613,844 | 3.1% |
| NanoString Technologies IncSold out | February 14, 2024 | 0 | 0.0% |
| Oncocyte Corp | February 14, 2024 | 708,172 | 8.4% |
| Quanterix Corp | February 14, 2024 | 1,935,441 | 5.2% |
| Sonendo, Inc. | February 14, 2024 | 5,422,384 | 10.0% |
| ViewRay, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| CUTERA INC | December 29, 2023 | 1,270,494 | 6.4% |
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.